Your session is about to expire
← Back to Search
Homelessness Diversion for Emergency Department Patients Facing Homelessness
N/A
Waitlist Available
Led By Jack Tsai, PhD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, month 1, month 2, month 3, month 4, month 5 and month 6
Awards & highlights
Study Summary
This trial investigates whether a homelessness program in a hospital ED can reduce visits & tailor services to meet diverse needs.
Who is the study for?
This trial is for English or Spanish speakers discharged from a Harris Health Hospital ED who are at imminent risk of homelessness and have Medicaid, Medicare, or no insurance. It's not for those with a legal guardian or plans to leave Texas within 6 months.Check my eligibility
What is being tested?
The study is testing if integrating Homelessness Diversion (HD) services into the emergency department discharge process can reduce future ED visits. It compares HD support against the usual treatment patients receive when leaving the hospital.See study design
What are the potential side effects?
Since this trial involves social service interventions rather than medical treatments, traditional side effects are not applicable. However, there may be varying personal experiences with the diversion program.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, month 1, month 2, month 3, month 4, month 5 and month 6
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, month 1, month 2, month 3, month 4, month 5 and month 6
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Number of ED visits
Secondary outcome measures
Change in health related quality of life as assessed by the Short Form-12 version 2.0 (SF12v2) health Survey
Number of participants who experience homelessness
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Homeless diversion (HD) groupExperimental Treatment1 Intervention
Group II: Treatment-as-usual (TAU) groupActive Control1 Intervention
Find a Location
Who is running the clinical trial?
The University of Texas Health Science Center, HoustonLead Sponsor
903 Previous Clinical Trials
319,977 Total Patients Enrolled
1 Trials studying Homelessness
40 Patients Enrolled for Homelessness
National Institute on Minority Health and Health Disparities (NIMHD)NIH
382 Previous Clinical Trials
1,215,161 Total Patients Enrolled
Jack Tsai, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
1 Previous Clinical Trials
30 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I speak English or Spanish.
Research Study Groups:
This trial has the following groups:- Group 1: Homeless diversion (HD) group
- Group 2: Treatment-as-usual (TAU) group
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Can new patients still enroll in this experiment?
"Unfortunately, the records available on clinicaltrials.gov indicate that this trial is not presently enrolling patients. Initially posted in May of 2023 and last modified on April 8th, there are no current openings here; however, 213 other trials are currently taking applicants."
Answered by AI
Share this study with friends
Copy Link
Messenger